Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Arcutis Biotherapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Arcutis Biotherapeutics Inc. June 14, 202490.6%
-
CytomX Therapeutics Inc. May 15, 202482.0%
-
Vaxcyte Inc. June 13, 202387.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Vaxcyte Inc. | Grant or award | +2,265 | — | — |
| Jun 5, 2026 | Arcutis Biotherapeutics Inc. | Grant or award | +5,778 | — | — |
| Nov 20, 2025 | Arcutis Biotherapeutics Inc. | Option exercise | +12,220 | $7.51 | $91,772 |
| Nov 20, 2025 | Arcutis Biotherapeutics Inc. | Open-market sale | −16,532 | $27.55 | $455,457 |
| Jun 12, 2025 | Arcutis Biotherapeutics Inc. | Grant or award | +7,609 | — | — |
| Jun 12, 2025 | Vaxcyte Inc. | Grant or award | +3,041 | — | — |
| Jun 14, 2024 | Arcutis Biotherapeutics Inc. | Grant or award | +10,139 | — | — |
| Jun 6, 2024 | Vaxcyte Inc. | Grant or award | +1,550 | — | — |
| Jun 3, 2024 | Vaxcyte Inc. | Option exercise | +18,200 | $5.35 | $97,370 |
| Jun 3, 2024 | Vaxcyte Inc. | Open-market sale | −18,200 | $73.00 | $1,328,600 |
| Jun 13, 2023 | Vaxcyte Inc. | Grant or award | +2,500 | — | — |
| May 31, 2023 | Arcutis Biotherapeutics Inc. | Grant or award | +4,375 | — | — |
Questions about Halley E. Gilbert
What boards is Halley E. Gilbert on?
Halley E. Gilbert sits on the boards of Arcutis Biotherapeutics Inc., CytomX Therapeutics Inc. and Vaxcyte Inc.
How long has Halley E. Gilbert served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.